InsidersTradesSigma
동성제약: directors' dealings · South Korea · DART (FSS)
DART:company-25c289KR·DART (FSS)Mcap 105.9Bn€
Explore the full management transaction log of 동성제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €105.9bn. The latest transaction was disclosed on 6 April 2026 (Purchase). Among the most active insiders: 태광산업. The full history is free.
3
Insider Decl.
0
Thresholds
€40m
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
973.00 €
Income statement
Revenue87.17 Bn€
Gross profit37.11 Bn€43% margin
Net income−25.74 Bn€-29.5% margin
Balance sheet & cash
Market cap105.87 Bn€
Total debt64.13 Bn€
Free Cash Flow−14.20 Bn€
Last declaration on 6 April 2026
Declarations3 total
Executives●Purchase12DART
€18m31,500,000 shares@ €0.5750.017% mcap100.0% of flow
ShareKRX
DART:20260406003057·
Ideal exit: 26 Dec 2026 (T+270)
Executives●Purchase10DART
€5m8,500,000 shares@ €0.5750.0046% mcap100.0% of flow
ShareKRX
DART:20260406003088·
Ideal exit: 26 Dec 2026 (T+270)
3 of 3 declarations